Michael Leuchten
analystMale0.0Global Dominance: 0.00%
Michael Leuchten is an analyst at Jefferies, known for his expertise in the healthcare sector, particularly in evaluating pharmaceutical companies like GSK. His insights often focus on earnings performance and market expectations, providing valuable analysis for investors navigating the complexities of the healthcare market.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Michael Leuchten expressed his perplexity regarding the merger discussions between AstraZeneca and BMS.
Gerüchte um Megafusion zwischen AstraZeneca und BMS irritieren den MarktNeue Zürcher Zeitung·
Switzerland· 2026-08-03
Switzerland· 2026-08-03
Michael Leuchten from Jefferies praised GSK's revenue surprise in the second quarter as qualitatively convincing.
Qualitätsaktien für unsichere ZeitenNeue Zürcher Zeitung·Switzerland· 2026-07-31
Switzerland· 2026-07-31
